4D Molecular Therapeutics... (FDMT)
4D Molecular Therapeutics Statistics
Share Statistics
4D Molecular Therapeutics has 46.32M shares outstanding. The number of shares has increased by -10.45% in one year.
| 46.32M |
| -10.45% |
| 0.16% |
| 84.35% |
| n/a |
| 3,720 |
| 0.6% |
Short Selling Information
The latest short interest is 4.67M, so 10.08% of the outstanding shares have been sold short.
| 4.67M |
| 10.08% |
| 10.49% |
| 9.03 |
Valuation Ratios
The PE ratio is -1.87 and the forward PE ratio is -0.99. 4D Molecular Therapeutics's PEG ratio is -0.12.
| -1.87 |
| -0.99 |
| 8120.72 |
| 1.4 |
| 0.59 |
| -2.17 |
| -0.12 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for 4D Molecular Therapeutics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 14.92, with a Debt / Equity ratio of 0.05.
| 14.92 |
| 14.92 |
| 0.05 |
| -0.13 |
| -0.18 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $163 |
| $-708,669.6 |
| 227 |
| 0 |
| n/a |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by -82.81% in the last 52 weeks. The beta is 2.83, so 4D Molecular Therapeutics's price volatility has been higher than the market average.
| 2.83 |
| -82.81% |
| 3.3 |
| 6.84 |
| 60.35 |
| 616,876 |
Income Statement
In the last 12 months, 4D Molecular Therapeutics had revenue of 37K and earned -160.87M in profits. Earnings per share was -2.98.
| 37K |
| 37K |
| -187.84M |
| -160.87M |
| -187.84M |
| -187.84M |
| -2.98 |
Balance Sheet
The company has 149.34M in cash and 24.61M in debt, giving a net cash position of 124.73M.
| 149.34M |
| 24.61M |
| 124.73M |
| -576.2M |
| 515.73M |
| 305.67M |
Cash Flow
In the last 12 months, operating cash flow was -134.59M and capital expenditures -3.79M, giving a free cash flow of -138.37M.
| -134.59M |
| -3.79M |
| -138.37M |
| -2.57 |
Margins
Gross margin is 100%, with operating and profit margins of -507678.38% and -434778.38%.
| 100% |
| -507678.38% |
| -434778.38% |
| -434778.38% |
| -507678.38% |
| -507678.38% |
| -373975.68% |
Dividends & Yields
FDMT does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for FDMT is $37, which is 853.6% higher than the current price. The consensus rating is "Buy".
| $37 |
| 853.6% |
| Buy |
| 10 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| -0.19 |
| 2 |